Download PDF
Open Access
CC BY-NC-ND 4.0 · Avicenna J Med 2021; 11(01): 33-39
DOI: 10.4103/ajm.ajm_110_20
Original Article

Dose adjustment of antidiabetic medications in chronic kidney disease

Authors

  • Matthew Salvatore Snyder

    New York Institute of Technology College of Osteopathic Medicine, 101 Northern Boulevard, Old Westbury, NY, USA

  • Joshua Fogel

    Department of Business Management, Brooklyn College, 218 Whitehead Hall, Brooklyn, NY, USA

  • Svetlana Pyatigorskaya

    Division of Nephrology and Hypertension, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY, USA

  • Sofia Rubinstein

    Division of Nephrology and Hypertension, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY, USA

Subject Editor:
Financial support and sponsorship Nil.
Further Information
Also available at
  Permissions and Reprints
Preview

Abstract

Purpose: The purpose of this study is to identify whether Internal Medicine house-staff (IMHS) have awareness and knowledge about the correct dosage of antidiabetic medications for patients with chronic kidney disease (CKD), as dosing errors result in adverse patient outcomes for those with diabetes mellitus (DM) and CKD. Methods: There were 353 IMHS surveyed to evaluate incorrect level of awareness of medication dose adjustment in patients with CKD (ILA) and incorrect level of knowledge of glomerular filtration rate level for medication adjustment (ILK-GFR) for Glipizide, Pioglitazone, and Sitagliptin. Results: Lack of awareness and knowledge was high, with the highest for Pioglitazone at 72.8%. For ILA, the percentages were: Pioglitazone: 72.8%, Glipizide: 43.9%, and Sitagliptin: 42.8%. For ILK-GFR, the percentages were: Pioglitazone: 72.8%, Glipizide: 68.3%, and Sitagliptin: 65.4%. Conclusions: IMHS have poor awareness and knowledge for antidiabetic medication dose adjustment in patients with DM and CKD. Both Electronic Medical Rerecord best practice advisory and physician–pharmacist collaborative drug therapy management can enhance safe drug prescribing in patients with CKD. In addition, IMHS’s practice for antidiabetic medication dose adjustment was better with Nephrology exposure. A formal didactic educational training during medical school and residency for antidiabetic medication dose adjustment in patients with DM and CKD is highly encouraged to prevent medication dosing errors and to more effectively and safely allow IMHS to manage complex treatment regimens.

Keywords

Adult-onset diabetes mellitus - chronic kidney insufficiency - internal medicine - medication error - residency and internship


Publication History

Article published online:
06 August 2021

© 2021. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India